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Background: Adverse drug reactions, poor patient adherence and errors, here collectively referred to as
medication-related harm (MRH), cause around 2.7-8.0% of UK hospital admissions. Communication gaps between
successive healthcare providers exist, but little is known about how MRH is recorded in inpatients’ medical records.
We describe the presence and quality of MRH documentation for patients admitted to a London teaching hospital
due to MRH. Additionally, the international classification of disease 10th revision (ICD-10) codes attributed to confirmed
MRH-related admissions were studied to explore appropriateness of their use to identify these patients.
Methods: Clinical pharmacists working on an admissions ward in a UK hospital identified patients admitted due to
suspected MRH. Six different data sources in each patient’s medical record, including the discharge summary, were
subsequently examined for MRH-related information. Each data source was examined for statements describing the
MRH: symptom and diagnosis, identification of the causative agent, and a statement of the action taken or considered.
Statements were categorised as ‘explicit’ if unambiguous or ‘implicit’ if open to interpretation. ICD-10 codes attributed
to confirmed MRH cases were recorded.
Results: Eighty-four patients were identified over 141 data collection days; 75 met our inclusion criteria. MRH
documentation was generally present (855 of 1307 statements were identified; 65%), and usually explicit (705 of 855;
82%). The causative agent had the lowest proportion of explicit statements (139 of 201 statements were explicit; 69%).
For two (3%) discharged patients, the causal agent was documented in their paper medical record but not on the
discharge summary. Of 64 patients with a confirmed MRH diagnosis at discharge, only six (9%) had a MRH-related
ICD-10 code.
Conclusions: Availability of information in the paper medical record needs improving and communication of
MRH-related information could be enhanced by using explicit statements and documenting reasons for changing
medications. ICD-10 codes underestimate the true occurrence of MRH.
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There are several ways in which use of medicines can
lead to harm. First, even correctly prescribed and cor-
rectly used medicines can harm through side-effects or
unanticipated allergic reactions, ranging from minor to
potentially fatal [1]. Second, errors may occur at any step* Correspondence: Matthew.reynolds@imperial.nhs.uk
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unless otherwise stated.between prescribing and administering a drug: prescrib-
ing errors, dispensing errors, monitoring errors and ad-
ministration errors [2,3] all have potential to cause harm
which may be sufficient to warrant hospitalisation [2].
Finally, harm may arise through incorrect use, or non-use,
by the patient. In this paper, we use the term medication-
related harm (MRH) to encompass harm due to any or
all of these three types of harm: adverse drug reactions
(ADRs), medication errors, and poor adherence [4]. Other
studies focus on adverse drug events; these generally ex-
clude harm due to poor adherence.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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hospital admissions caused by MRH encompassing all
three types of harm, there are various studies of the sep-
arate components. For example, using medical record
review, ADRs and adherence problems [4-6] and ADRs
exclusively [7,8] have been shown to contribute to 2.7-
8.0% of admissions to UK hospitals [4-8]. These figures
are comparable to a recent international systematic re-
view [9] which concluded that 5.8% of admissions are
caused by ADRs. The estimated cost of ADRs to the Na-
tional Health Service (NHS) in England is £466 m annu-
ally [7]. Harm due to poor adherence, and harm due to
medication errors have also been identified as contribut-
ing to hospital admissions both in the UK and inter-
nationally [4,10].
Patients’ care pathways are complex and multiple care
providers are often involved, even during a single hospital
stay. With each care decision there is a risk that informa-
tion may not be passed onto the next care provider in suffi-
cient quality to ensure continuity of decision making and
full understanding of previous decisions; such failures in
communication have been identified as contributing to
medication errors [3,11]. The failure to properly communi-
cate patient information in general, and medication infor-
mation in particular, has been identified in a number of
different healthcare settings [3,11-14], despite guidance on
how to document medication changes [11,15]. To ensure
continuity of care, it is particularly important to have ef-
fective communication between hospital prescribers and
community-based General Practitioners (GPs) and com-
munity pharmacists who are often responsible for continu-
ing medication started, or changed, in hospital. Within the
UK, it has been suggested that incomplete discharge com-
munication, including incomplete medication information,
can lead to preventable readmissions [12]. Re-prescribing of
medication discontinued or changed in response to MRH
can also be responsible for patient re-admission [16,17],
although few UK data are available. It is not currently
known how MRH information is documented in the UK
hospital setting, and whether the nature of MRH docu-
mentation contributes to communication gaps between
hospital and community settings.
In this exploratory study in one hospital, our aim was to
examine how MRH contributing to hospital admission was
documented in patients’ medical records at admission, at
transfer between hospital wards, and at discharge. Specific-
ally we report on 1) which aspects of MRH were recorded
within patients’ medical records and where; 2) what infor-
mation relating to the MRH and the causal medicines was
communicated back to the GP via the hospital discharge
communication; 3) how the quantity and quality of infor-
mation changed throughout the patient’s admission, and
4) which International Classification of Diseases (ICD-10)
codes were attributed to MRH-related admissions.Methods
Setting
The study used prospective review of inpatients’ medical
records in a large London teaching hospital. Multidiscip-
linary medical records were mainly paper-based, as is
typical at present in the UK, and included various pro-
formas for different aspects of care. For patients admit-
ted via the accident and emergency department (A&E),
the triaging nurse completed a brief one-page triage pro-
forma. Subsequently, a multi-page A&E clerking pro-
forma which included an in-depth initial assessment of
the initial admission was completed by the admitting
A&E doctor. The chronological handwritten case notes
and treatment plans provided a diary of patients’ on-
going care. Inpatient prescribing was paper-based, using
preformatted drug charts typical within the UK; [18]
electronic discharge summaries (Electronic Discharge
Communication; EDC) were computer-generated using
locally developed discharge prescribing software. Users
of the EDC system were prompted to enter information
in specific sections which were then printed for dispens-
ing of discharge medication. The EDC comprised a dis-
charge prescription, synopsis of the inpatient admission
and recommendations for future management; it was
sent to primary care providers after discharge.
Initial patient identification took place on a 26-bed
adult acute medical admissions ward. A clinical pharma-
cist (“admissions pharmacist”) and often a pharmacy
technician were present on the ward between 8 am and
6.30 pm every weekday and between 8 am and 1 pm
most weekends. The pharmacist attended the multi-
disciplinary post-take ward round (PTWR) at 8 am daily,
during which the duty medical team reviewed all pa-
tients admitted during the previous 24 hours. Diagnoses,
decisions and management plans were recorded on a
one-page PTWR proforma. The pharmacist and phar-
macy technician also performed medication reconcili-
ation on admission, reviewed each patient’s medication,
and resolved any problems identified.
The study was registered within the relevant NHS
trust as a service evaluation in line with local guidance
and did not require ethics approval.
Data collection
We collected data for patients admitted between 10
October 2011 and 6 June 2012, inclusive of those admit-
ted on weekends and public holidays.
Patients whose admissions were considered to have been
caused by MRH were identified by the admissions pharma-
cists during the PTWR following discussion with the multi-
disciplinary team; this was an implicit clinical judgement.
For each of these patients, we asked the pharmacist to
record brief details of the suspected causative medi-
cines, the corresponding MRH, and whether the MRH
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adherence problem. The pharmacist then evaluated the
relationship between the MRH and the hospital admis-
sion using Hallas’ criteria [19].
The investigator (MR) examined the pertinent sections
of the medical record of each included patient as soon as
possible after admission, and shortly after transfer or dis-
charge from the admissions ward. In total, six sections of
the complete medical record were examined; each section
corresponded to one of six chronological time-points dur-
ing a typical admission. At each of these six time-points
the relevant section of the medical record (“data source”)
was examined (Figure 1) and the presence and quality of
each of four different aspects of MRH (MRH statements,
Table 1) was recorded. All days of the patient’s admission
were eligible for data collection.
Five of the six chronological points corresponded to
transfers between hospital departments or providers of
care; we also studied entries in the handwritten case
notes up to and including 3 pm on the day of the PTWR
(data source 4, Figure 1). According to local guidelines,
this is the latest time by which patients reviewed on that
morning’s PTWR should have received medication recon-
ciliation and thus any additional information relating to
MRH would be documented by that time. Data collected
from source 4 enabled the content of the handwritten case
notes of patients discharged home from the admissions
ward to be compared with case notes of patients trans-
ferred to other wards. Information on the inpatient drug
chart was considered part of data sources 4 and 5.
This was an exploratory study therefore no formal
sample-size calculation was performed. The admissions
pharmacists review approximately 20 patients daily dur-
ing the PTWR; based on the existing literature [4-9] we
therefore expected around one or two admissions each
day to be caused by MRH. After discussion with our ad-
missions pharmacists, about five days of data collectionFigure 1 Overview of the six data sources showing which sections ofper week seemed feasible, and thus a cohort of about 225
patients with MRH over the 30 week course of the study
was expected, assuming 5 days data collection per week.
Inclusion and exclusion criteria
Patients were included in our analysis if the following
criteria were met:
 MRH was judged shortly after admission to be the
‘dominant’ cause or ‘partly contributing’ to the
admission [19],
 the patient was admitted via A&E and then
transferred to the admissions ward,
 the identifying pharmacist’s original summary was
detailed enough to permit the investigator to
identify the patient,
 data were subsequently collected from one or more
data sources (Figure 1).
Patients were excluded if they were admitted due to
malicious poisoning or deliberate overdose. Daily data
collection from the paper medical record was suspended
for any patients moved to a critical care area to avoid
disrupting care and to minimise unnecessary visits to
these areas as per infection control guidelines; the med-
ical record was instead reviewed after patient de-
escalation. Data collection for a given patient ceased if
their admission was subsequently confirmed to be unre-
lated to MRH, however data from previous data sources
recorded prior to a non-MRH diagnosis being estab-
lished were included in the analysis. The EDCs for pa-
tients subsequently diagnosed with a non-MRH problem
were only examined for a statement of symptoms.
Classification of MRH statements
Four different statements of MRH (Table 1) were sought
from each of the six data sources with the medical recordthe medical record were examined.
Table 1 Medication-related harm (MRH) statements
Statement number Statement relating to Example
1. The MRH symptom “fall”
2. The MRH diagnosis “drug-induced hypotension”
3. Identification of the causative drug “hypotension caused by anti-hypertensives”
4. The action already taken or planned in relation to the causative agent “bisoprolol stopped”
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sional guidelines [15] as well as local policy in relation to
what should be recorded in patients’ medical records.
The presence or absence of each of these four types of
statement in each data source was established. Identified
statements were then defined as either ‘explicit’, if the
statement was judged to be unambiguous, or ‘implicit’
for those open to interpretation. If multiple statements
were identified, the most specific was recorded.
Data analysis
Descriptive statistics were used to present the presence
of implicit and explicit statements of MRH in each of
the six data sources.
To assess inter-rater reliability of the researcher’s inter-
pretations of MRH statements, a senior pharmacist external
to the project independently categorised 180 MRH state-
ments from nine randomly selected patients’ complete
medical records as explicit, implicit, or absent. These classi-
fications were compared with the investigator’s using a
weighted kappa statistic with quadratic weighting [20].
ICD-10 codes
All unique ICD-10 codes attributed to each patient with a
documented confirmed or suspected diagnosis of MRH
were examined for codes related to ADRs, unintentional
poor adherence, or substances used in error (codes Y40-
59, X40-X49, T36-T50 and 58 other individual MRH-
related codes, Additional file 1)
Results
Admissions due to MRH
A total of eight admission pharmacists collected data on
141 (59%) of 240 days between 10 October 2011 and 6 June
2012; pharmacists’ routine workload prevented data collec-
tion on the remaining days. Of the 1,237 patients reviewed
by admission pharmacists, 84 (6.8%) were suspected shortly
after admission as being admitted due to MRH. Of these,
nine were subsequently excluded (Figure 2); 75 (6.1% of all
patients reviewed) were therefore included in the analysis.
MRH types and drugs implicated in admissions
The types of MRH suspected as causing admission are
categorised in Table 2; 95 different drugs were implicated
in the 64 MRH-related admissions. Some admissions were
related to multiple drugs.Most admissions were caused by ADRs or adherence
problems. Overall, 64/75 (85%) patients initially sus-
pected as being admitted due to MRH subsequently had
a diagnosis of MRH confirmed and recorded within their
medical record. The remaining 11/75 (15%) patients
were subsequently diagnosed with a non-MRH-related
problem by the medical team; these patients’ EDCs were
therefore examined for statements of symptoms only.
Extraction of MRH information from the complete
medical record
Patients had either five or six possible sources of data ex-
amined depending on whether they changed wards as an
inpatient. This resulted in a total of 409 data sources for 75
patients. Complete data were collected for 53 (71%) pa-
tients (n = 291 data sources). Medical records were missing
single data sources for four of the 53 patients: all the avail-
able data were collected and they were therefore classified
as complete. For the remaining 22 (29%) patients, 44 (37%)
of 118 possible data sources were examined. Overall, data
were collected from 335 (82%) of the 409 potential chrono-
logical data sources.
For 16 patients, data could not be collected from the
first four data sources as the paper medical record was
sent to central storage before data collection was com-
pleted. The paper medical records of a further six pa-
tients were also sent to central storage before the case
notes at transfer could be examined.
Documentation of medication related harm within the
complete medical record
In total 855/1307 (65%) of all possible statements were
present, either implicitly or explicitly. The presence of
MRH-related information in each of the data sources
varied considerably, Table 3.
Symptoms were documented well at A&E triage (55
statements in 59 A&E Triage documents examined, 93%).
An increase in documentation of diagnosis, identification
of the causative agent, and action or plan then occurred at
A&E clerking, see Additional file 2. For example, the sus-
pected causative agent was stated in 17/59 (29%) of A&E
Triage data sources and in 40/58 (69%) of A&E Clerking
data sources.
When all data sources within the paper medical record
(sources 1–5) were considered as a whole, the major symp-
tom was mentioned at least once within the entire record
Figure 2 Patient inclusion flowchart (MRH =Medication-related harm).
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tive agent in 54 (92%), and a statement of the action/plan in
52 (88%). Explicit statements of the symptom were found in
58 (98%) of all cases, of diagnosis in 50 (85%), of causative
agent in 47 (80%), and of action/plan in 49 (83%) of all cases.
MRH information availability on the discharge
communication
The EDC was the most complete individual data source
overall, with 247 (93%) of 267 possible statements present,
Table 3. Of these 247 statements, 200 (81%) were explicitTable 2 Types of suspected medication-related harm admissio
Drug group Adverse drug reactions (AD
Diuretics 16
Anti-epileptics 2
Drugs used in diabetes 2
Beta blockers 4
Anti-platelets 5
Anticoagulants 4
Opioid analgesics 4
Drugs affecting the renin-angiotensin system 3
Calcium channel blockers 3
Anti-infectives 3
Anti-depressants 3
Positive inotropes 2
Other groups implicated once 15
Total 66
Total patients 45 (70%)
Groups based on British National Formulary [1] categories.and 47 (19%) implicit. The symptoms of MRH were men-
tioned in 68 (91%) of 75 cases, and explicitly in 65 (96%) of
those. The greatest ambiguity was found in the MRH diag-
nosis statements: 59 (92%) of 64 statements were present,
with only 38 (64%) explicit. The causative agent was stated
in 60 (94%) of 64 cases, with 43 (72%) explicit. A statement
of the action taken or plan for the causative agent was
found in 60 (94%) of 64 possible instances; 54 (90%) were
explicit.
In total, information regarding 14 statements was not
transferred from the paper medical record to the EDC;ns and drugs implicated
R) Adherence Error ADR & Error Adherence & Error Total
1 17
8 1 11
4 1 7
2 6
5
1 5
1 5
1 1 5
1 4
1 4
3
1 3
3 2 20
23 4 1 1 95
15 (23%) 2 (3%) 1 (2%) 1 (2%) 64 (100%)
Table 3 Overview of statement presence in each of the six data sources
Data source No. of statements judged explicit
(% of total possible statements)
No. of statements judged implicit
(% of total possible statements)
Total/possible
(% of total possible statements)
1. Accident & Emergency
(A&E) Triage form
88 (37%) 23 (10%) 111/236 (47%)
2. A&E Clerking form 146 (63%) 21 (9%) 167/232 (72%)
3. Post-take ward
round form
144 (50%) 34 (12%) 178/228 (78%)
4. Handwritten case
notes at 3 pm
95 (42%) 17 (7%) 112/228 (49%)
5. Handwritten case
notes at transfer
32 (28%) 8 (7%) 40/116 (35%)
6. Electronic Discharge
Communication
200 (75%) 47 (18%) 247/267 (93%)
Total 705 150 855/1307 (65%)
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of diagnosis information, and two each of causative
agent and action taken/plan.
Conversely, seven additional statements were found on
the EDC which were not found in any of the data
sources within the paper medical record; four of these
related to the action taken/ future plan for the causative
agent. The full breakdown of results is presented in
Additional file 2.
In some cases, although relevant statements were
present on the EDC and thus included in our data, they
were located in a section not intended for clinical com-
munication, such as the ‘details of information booklets
and other information given with medicines’ section and
so potentially would be missed by recipients of this
documentation.
Inter-rater reliability
The weighted kappa statistic for inter-rater reliability of
whether statements were explicit, implicit or absent was
0.5, corresponding to ‘fair agreement’ [20].
Coding of admissions
The 64 patients with a confirmed diagnosis of MRH
somewhere in their complete medical record had 475
ICD-10 codes assigned (median 7, range 2–15). One pa-
tient admitted with adherence problems had an MRH-
related primary diagnosis (assigned ICD-10 code E16.0,
drug-induced hypoglycaemia without coma) and one sec-
ondary diagnosis (Y42.3, Drugs, medicaments and bio-
logical substances causing adverse effects in therapeutic
use, Insulin and oral hypoglycaemic drugs). Three patients
admitted due to ADRs were assigned two MRH codes in
the secondary diagnosis field, and two further patients ad-
mitted due to ADRs were assigned one relevant code. A
total of six (9%) of 64 patients therefore had one or more
MRH-related ICD-10 codes assigned to their admission;
five of the six had explicit statements relating to the MRHdiagnosis on their EDC, Table 4. Of the 58 patients not at-
tributed a MRH-related ICD-10 code, 33 (57%) had an ex-
plicit diagnosis on their EDC, 21 (36%) were implicit, and
4 (7%) had none.
Discussion
We found 64/1237 (5.2%) of admissions to be caused by
MRH. In general, this MRH was fairly well documented
in all sources examined within the complete medical
record. However, failure to transfer information from in-
patients’ medical records to discharge summaries was
identified, and there was no one place within the paper
medical record where complete MRH information was
consistently found. Finally, less than one in ten patients
with a confirmed MRH-related diagnosis had this
reflected in their ICD-10 codes.
Interpretation and implications for practice
The A&E triage data source contained a symptom state-
ment in 93% cases. A substantially higher percentage of
A&E clerking documents included statements of diagno-
sis, identification of the causative agent, and action or
plan than A&E triage.
The one-page PTWR form should capture concise,
specific information about a patient’s diagnosis and
management plan. Documentation of all potential MRH
statements was found in at least 65% of the PTWR data
sources. The percentage of implicit statements within this
source was relatively high (23% of all cases). However, the
PTWR doctors’ time–pressure [21] may be reflected in
the use of the single-word or very short statements identi-
fied, perhaps assuming the next reader will link together
the information on the PTWR form with that mentioned
elsewhere within the patient’s medical record [22].
Of interest was the contribution the contents of the
drug chart made to increasing overall documentation in
the 3 pm data source. This suggests that the drug chart is
not only used as a record of prescribed and administered
Table 4 Electronic Discharge Communication statements, with associated International Classification of Diseases (ICD)
10 codes
Excerpt no. Statement ICD-10 code
1. “main condition: drug induced neutropaenia” Y41.0
2. “the diagnosis was lactic acidosis, secondary to EtOH [ethanol] excess and metformin” Y49.2 and Y51.3
3. “main condition: medication induced delirium” Y49.2 and Y51.3
4. “main condition: lithium toxicity” X49.9
5. “Digoxin (change reason, stopped due to toxicity)” X44.9 and T46.0
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mation which may not be found elsewhere. As electronic
prescribing systems become more widespread, it will be im-
portant to consider whether these systems can also be used
to document this additional contextual information.
In total, information regarding 14 statements was not
transferred from the paper medical record to the EDC;
conversely, seven additional statements were found on
the EDC and not in the paper medical record. The pres-
ence of additional statements on the EDC may reflect
new information discovered during the patient’s stay.
The data collection method for this study focussed pri-
marily on the first two or three days after admission,
and at discharge. Information regarding a patient’s con-
dition which was established after first ward-transfer and
documented in the paper medical notes before discharge
was not collected. However, most of the information
presented at discharge was identified during the first two
or three days of patients’ hospital stays.
One aspect of MRH where a degradation of information
seemed to occur was illustrated by the decrease in per-
centage availability of symptom and diagnosis statements
between paper medical record and the EDC: there were
six instances of symptom information not being trans-
ferred to EDCs, and four instances of diagnosis informa-
tion not being transferred. This failure to transfer
information may be a reflection of the way the informa-
tion is spread throughout the inpatient record making
comprehensive transfer of information difficult. Patients’
medical records are often large and comprise many pages.
To provide an accurate discharge summary, the dischar-
ging doctor must condense and communicate information
dispersed throughout the entire paper medical record:
they must be able to identify the most recent and accurate
data entries on which to base their discharge summary. It
may be unreasonable to expect a discharging doctor to re-
view every patient’s entire medical record and extract all
relevant information. Electronic records may allow storage
of clinically important information in easier-to-navigate
patient chronologies, which would allow ready access to
the most up-to-date information. However, given current
variation in extent and approach to electronic health rec-
ord system use within the UK, more work is likely to be
needed to realise these potential benefits [23].Four or five different data sources were examined in
the paper medical record compared with one at dis-
charge; therefore poor documentation within individual
sources in the paper medical record does not necessarily
translate into poor cumulative availability when patients’
paper medical records are considered as a whole.
Overall, our findings suggest that while key informa-
tion is generally transferred onto the EDC, important in-
formation is sometimes lost. As failure to pass on
information has been identified as a patient care prob-
lem [3,11-14] there may be potential to avoid injury at
minimal cost to the NHS by encouraging and facilitating
better communication of the information which already
exists in patients’ medical records.
Regarding the structure of the EDC specifically, there
were instances when the statement relating the causative
agent to the symptom or diagnosis was in an inappropri-
ate section of the EDC. The person who made the entry
was not always stated, but some entries were specifically
attributable to pharmacists. For instance, relevant infor-
mation was sometimes found in the “details of informa-
tion booklets and other information given with medicines”
section or the “additional notes” section where pharma-
cists can add additional comments. The pharmacist may
add valuable medicine-related information to the EDC but
the next reader may not be alerted to this information be-
cause it is printed in an unexpected section of the EDC.
Future EDC systems must allow both doctors and phar-
macists to make entries in a section of the EDC dedicated
to medication changes, and to enable easy documentation
of MRH.
The role of patient adherence as a contributing factor to
admission was sometimes poorly communicated on the
EDC; in one instance there was no indication that a patient
admitted following a collapse had mistakenly taken their
anti-hypertensive medicines twice. Adherence problems
commonly fall to primary care providers to manage; it is
therefore crucial that this be communicated to GPs and to
community pharmacists wherever possible. However, as
the patient is discharged with a copy of the EDC, the dis-
charging doctor may be reluctant to apportion them blame
and possibly cause offence, or wary of making statements
based on potentially inaccurate assumptions in the medical
records. Discharging doctors are unlikely to have admitted
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with the patient to document culpability.
ICDs related to MRH were rarely used. Although we
studied a small sample of patients from one organisa-
tion, the lack of MRH-related coding was notable. Both
health care planning and research are underpinned by good
quality evidence based on accurate data. Since coders use
patients’ complete medical records as the primary source of
information for coding, the accuracy of coding is likely to
reflect the clarity of that medical record. Although MRH
information was present in most cases, it was often in a
format which needed interpretation, and was spread
throughout the entire record. The EDC often provides a
more interpretable (81% explicit statements) and ac-
cessible summary, and use of unambiguous statements
(e.g. drug induced neutropenia) may facilitate assign-
ment of MRH-related ICD codes.
Implications for research
Investigation into the reasons for the ambiguousness of
some information on the PTWR form data source may en-
able improvement of the PTWR form, or contribute to the
restructuring of the PTWR. Future research should also ex-
plore how GPs, community pharmacists, patients and other
recipients interpret MRH-related information on patients’
discharge communications and how this information is
acted upon. The reasons for failing to document adher-
ence problems should also be explored, as should the rea-
sons why doctors use implicit or short statements within
the medical record, and whether use of explicit or implicit
statements is related to the probability that the admission
was MRH-related.
Any work reporting a rate of MRH-related admissions
calculated only using routinely collected ICD-10 codes is
likely to underestimate the true occurrence. Exploring
the reasons why ICD-10 codes are not used for MRH-
related admissions should be a next step.
Comparison with existing literature
The 5.2% (64 of 1,237) of patients admitted and diag-
nosed with MRH is in line with previous UK studies
[4-6] using similar data collection methods, but focus-
sing only on admissions caused by ADRs and poor ad-
herence, which report 5.3-8.0%, and with international
figures [9,24]. We also included admissions due to errors
but these were responsible for only five admissions. We
also found the causative agents to be similar to those re-
ported elsewhere [25].
The ICD codes attributed to each hospital admission
have previously been used to identify ADR-related admis-
sions [26,27], while others suggest that using ICD codes
underestimates their true occurrence [28,29].
In our study a total of 6 (0.5%; 95% confidence interval
0.1-0.9%) of 1237 admissions were found to have one ormore MRH-related ICD-10 codes. Wu et al. [26] found
557,978 of 59,718,694 (0.9%) of admissions over a ten
year period to have an ADR-related ICD-10 code. When
Wu et al.’s inclusion criteria are applied to the present
sample, only 3 (0.2%; 95% confidence interval 0.0-0.5%)
of our 1237 admissions had an ICD-10 code from the se-
lection of ICD codes used by Wu et al. It is not clear
why the proportion of admissions coded as being due to
ADRs was lower in our study, but may be due to our
sample being much smaller and from a more specific ad-
mission pathway in just one hospital.
Strengths and limitations
As well as being the first study to explore these issues, a
particular strength of our study is that MRH-related ad-
missions were detected during the PTWR, when each
patient is examined by a multi-disciplinary team with
great experience in detecting causes of admission, thus
the diagnosis of MRH reflects the opinion of a team, ra-
ther than a single individual.
Limitations include the fact that the contents of the
patient’s handwritten case notes were only examined up
to the time of first ward transfer (typically two or three
days after admission). As patients in our sample stayed
for up to 65 days, it is unsurprising that extra informa-
tion was found on the discharge summary when com-
pared with those data sources examined in the first few
days of admission. Furthermore, we were not able to
capture information from every data source for every pa-
tient, reducing the completeness of the data set. Data
collection took place between October and June and so
any seasonal variation may not be fully represented.
The inter-rater reliability testing performed for categor-
ising the presence of MRH-related information showed
only ‘fair’ agreement, and our sample was relatively small.
We did not explore whether agreement was affected by
the profession of the assessor. Finally, while we recorded
whether or not MRH was predominantly caused by error
we did not assess the preventability of other types of
MRH detected.
Conclusion
MRH was documented fairly well throughout the paper
medical record and at discharge. However, in line with
previous work, communication gaps were found. In-
stances where relevant information within the paper med-
ical record was omitted from the EDC were discovered.
Complete MRH information was not consistently found
in any single source within the medical record, which may
contribute to gaps in communication. Closing these gaps
may reduce the burden of MRH on the NHS and indivi-
dual patients. The limitations of using ICD codes to iden-
tify MRH should be clearly understood before drawing
inferences from them.
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Additional file 1: International classification of diseases codes
covering medication-related harm. This table shows all included
international classification of disease (ICD-10) codes, and is referenced in
the text as “Additional file 1”.
Additional file 2: Presence of implicit and explicit statements
throughout the complete medical record. This table shows all results
from each data source, and is referenced in the text as “Additional file 2”.
Footnotes: *‘Cumulative availability’ was defined as the presence of a
statement within the medical notes up and including the data source in
question. In cases where explicit and implicit statements are present, only
the explicit statement is counted in the numerator. #‘Cumulative
opportunity to state’ is the total number of individual patients for whom at
least one data source was examined up to and including that data source.
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